Literature DB >> 21194388

HMGB1 and microparticles as mediators of the immune response to cell death.

David S Pisetsky1, Julie Gauley, Anirudh J Ullal.   

Abstract

In a wide variety of diseases, cell death represents both an outcome and an important step in pathogenesis. This duality occurs because cell death leads to the extracellular release of molecules and structures that can potently induce the innate immune system. These mediators include the alarmins which are endogenous cellular constituents that exit activated or dying cells to stimulate toll-like receptors (TLRs) as well as non-TLR receptors. Of alarmins, the nonhistone protein HMGB1 is the prototype. Like DNA and RNA, HMGB1 can translocate from cells as they die. The activity of HMGB1 may reflect its interaction with other molecules such as LPS, DNA, and cytokines. In addition to alarmins, dead and dying cells can release subcellular organelles called microparticles that contain cytoplasmic and nuclear constituents, including DNA and RNA. These particles can impact on many cell types to induce inflammation. The release of HMGB1 and microparticles shows important similarities, occurring with cell death as well as stimulation of certain but not all TLRs. Furthermore, nitric oxide can induce the release of both. These observations suggest that the products of dead cells can serve as important mediators to drive immune responses and promote inflammation and autoreactivity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21194388      PMCID: PMC3166182          DOI: 10.1089/ars.2010.3865

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  65 in total

1.  The effects of CpG DNA on HMGB1 release by murine macrophage cell lines.

Authors:  Weiwen Jiang; Jianhua Li; Margot Gallowitsch-Puerta; Kevin J Tracey; David S Pisetsky
Journal:  J Leukoc Biol       Date:  2005-08-04       Impact factor: 4.962

2.  Preclinical evaluation of M30 and M65 ELISAs as biomarkers of drug induced tumor cell death and antitumor activity.

Authors:  Jeffrey Cummings; Cassandra Hodgkinson; Rajesh Odedra; Patrizia Sini; Simon P Heaton; Kirsten E Mundt; Tim H Ward; Robert W Wilkinson; Jim Growcott; Andrew Hughes; Caroline Dive
Journal:  Mol Cancer Ther       Date:  2008-03       Impact factor: 6.261

Review 3.  Molecular characteristics of immunogenic cancer cell death.

Authors:  A Tesniere; T Panaretakis; O Kepp; L Apetoh; F Ghiringhelli; L Zitvogel; G Kroemer
Journal:  Cell Death Differ       Date:  2007-11-16       Impact factor: 15.828

Review 4.  Innate apoptotic immunity: the calming touch of death.

Authors:  R B Birge; D S Ucker
Journal:  Cell Death Differ       Date:  2008-05-02       Impact factor: 15.828

5.  Life and times of a cellular bleb.

Authors:  Guillaume T Charras; Margaret Coughlin; Timothy J Mitchison; L Mahadevan
Journal:  Biophys J       Date:  2007-10-05       Impact factor: 4.033

6.  Apoptotic cells protect mice against lipopolysaccharide-induced shock.

Authors:  Yi Ren; Yi Xie; Guoping Jiang; Jianqing Fan; Joseph Yeung; Wen Li; Paul K H Tam; John Savill
Journal:  J Immunol       Date:  2008-04-01       Impact factor: 5.422

7.  The release of DNA into the plasma of mice following hepatic cell death by apoptosis and necrosis.

Authors:  Trinh T Tran; Pamela Groben; David S Pisetsky
Journal:  Biomarkers       Date:  2008-03       Impact factor: 2.658

8.  Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein.

Authors:  Hirotaka Kazama; Jean-Ehrland Ricci; John M Herndon; George Hoppe; Douglas R Green; Thomas A Ferguson
Journal:  Immunity       Date:  2008-07-18       Impact factor: 31.745

9.  HMGB1 develops enhanced proinflammatory activity by binding to cytokines.

Authors:  Yonggang Sha; Jaroslaw Zmijewski; Zhiwei Xu; Edward Abraham
Journal:  J Immunol       Date:  2008-02-15       Impact factor: 5.422

Review 10.  Secondary necrosis in multicellular animals: an outcome of apoptosis with pathogenic implications.

Authors:  Manuel T Silva; Ana do Vale; Nuno M N dos Santos
Journal:  Apoptosis       Date:  2008-03-06       Impact factor: 4.677

View more
  25 in total

1.  Plasmalemma permeability and necrotic cell death phenotypes after intracerebral hemorrhage in mice.

Authors:  Xiaoxia Zhu; Luyang Tao; Emiri Tejima-Mandeville; Jianhua Qiu; Juyeon Park; Kent Garber; Maria Ericsson; Eng H Lo; Michael J Whalen
Journal:  Stroke       Date:  2011-11-10       Impact factor: 7.914

Review 2.  Regulation of Posttranslational Modifications of HMGB1 During Immune Responses.

Authors:  Yiting Tang; Xin Zhao; Daniel Antoine; Xianzhong Xiao; Haichao Wang; Ulf Andersson; Timothy R Billiar; Kevin J Tracey; Ben Lu
Journal:  Antioxid Redox Signal       Date:  2016-02-05       Impact factor: 8.401

3.  Immunological cell type characterization and Th1-Th17 cytokine production in a mouse model of Gaucher disease.

Authors:  Manoj Kumar Pandey; Reena Rani; Wujuan Zhang; Kenneth Setchell; Gregory A Grabowski
Journal:  Mol Genet Metab       Date:  2012-04-30       Impact factor: 4.797

Review 4.  The danger from within: alarmins in arthritis.

Authors:  Meriam Nefla; Dirk Holzinger; Francis Berenbaum; Claire Jacques
Journal:  Nat Rev Rheumatol       Date:  2016-10-13       Impact factor: 20.543

5.  The extracellular release of DNA and HMGB1 from Jurkat T cells during in vitro necrotic cell death.

Authors:  Christian Beyer; Nancy A Stearns; Adreas Giessl; Jörg H W Distler; Georg Schett; David S Pisetsky
Journal:  Innate Immun       Date:  2012-02-16       Impact factor: 2.680

Review 6.  Inflammation in osteoarthritis: is it time to dampen the alarm(in) in this debilitating disease?

Authors:  M H J van den Bosch
Journal:  Clin Exp Immunol       Date:  2018-11-28       Impact factor: 4.330

7.  Kollidon VA64, a membrane-resealing agent, reduces histopathology and improves functional outcome after controlled cortical impact in mice.

Authors:  Lamin H Mbye; Eyup Keles; Luyang Tao; Jimmy Zhang; Joonyong Chung; Mykol Larvie; Rajani Koppula; Eng H Lo; Michael J Whalen
Journal:  J Cereb Blood Flow Metab       Date:  2011-11-16       Impact factor: 6.200

8.  Apicidin and docetaxel combination treatment drives CTCFL expression and HMGB1 release acting as potential antitumor immune response inducers in metastatic breast cancer cells.

Authors:  Maria Buoncervello; Paola Borghi; Giulia Romagnoli; Francesca Spadaro; Filippo Belardelli; Elena Toschi; Lucia Gabriele
Journal:  Neoplasia       Date:  2012-09       Impact factor: 5.715

Review 9.  Novel concepts on pregnancy clocks and alarms: redundancy and synergy in human parturition.

Authors:  Ramkumar Menon; Elizabeth A Bonney; Jennifer Condon; Sam Mesiano; Robert N Taylor
Journal:  Hum Reprod Update       Date:  2016-06-30       Impact factor: 15.610

Review 10.  Novel insights for high mobility group box 1 protein-mediated cellular immune response in sepsis: A systemic review.

Authors:  Li-Feng Huang; Yong-Ming Yao; Zhi-Yong Sheng
Journal:  World J Emerg Med       Date:  2012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.